Browsing by Author Lai, Yue-Yun

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 29 next >
Issue Date Title Author(s)
2016 B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature Zhu, Hong-Hu;Zhao, Xiao-Su;Qin, Ya-Zhen;Lai, Yue-Yun;Jiang, Hao
2016 CD38+CD58-is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients Li, Xu-Mian;Zhang, Le-Ping;Wang, Ya-Zhe;Lu, Ai-Dong;Chang, Yan;Zhu, Hong-Hu;Qin, Ya-Zhen;Lai, Yue-Yun;Kong, Yuan;Huang, Xiao-Jun;Liu, Yan-Rong
2012 Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance Jiang, Qian;Qin, Ya-Zhen;Lai, Yue-Yun;Jiang, Bin;Jiang, Hao;Shi, Hong-Xia;Huang, Xiao-Jun
2014 The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma Zhang, Yao;Bao, Li;Lu, Jin;Liu, Kai-Yan;Li, Jin-Lan;Qin, Ya-Zhen;Chen, Huan;Li, Ling-Di;Kong, Yuan;Shi, Hong-Xia;Lai, Yue-Yun;Liu, Yan-Rong;Jiang, Bin;Chen, Shan-Shan;Huang, Xiao-Jun;Ruan, Guo-Rui
2016 Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Qin, Ya-Zhen;Jiang, Qian;Jiang, Hao;Lai, Yue-Yun;Zhu, Hong-Hu;Liu, Yan-Rong;Jiang, Bin;Huang, Xiao-Jun
2017 Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib Qin, Ya-Zhen;Jiang, Qian;Lai, Yue-Yun;Jiang, Hao;Shi, Hong-Xia;Zhao, Xiao-Su;Liu, Yan-Rong;Huang, Xiao-Jun
2017 Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics Wang, Shu-Juan;Wang, Ping-Zhang;Gale, Robert Peter;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Jiang, Hao;Jiang, Qian;Zhang, Xiao-Hui;Jiang, Bin;Xu, Lan-Ping;Huang, Xiao-Jun;Liu, Kai-Yan;Ruan, Guo-Rui
2012 The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia Jiang, Qian;Zhao, Xiang-Yu;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Jiang, Bin;Huang, Xiao-Jun
2013 Efficacy and new mutation of Philadelphia-positive leukemia patients with highly nilotinib-resistant BCR-ABL mutations during dasatinib therapy Jiang, Qian;Qi, Ya-Zhen;Lai, Yue-Yun;Jiang, Bin;Jiang, Hao;Sh, Hong-Xia;Huang, Xiao-Jun
2019 High Aldehyde Dehydrogenase Activity at Diagnosis Predicts Poor Outcomes in Patients with T(8;21) Acute Myeloid Leukemia Yang, Lu;Zhang, Yan-Huan;Wang, Ya-Zhe;Chang, Yan;Li, Ling-Di;Chen, Wen-Min;Long, Ling-Yu;Lai, Yue-Yun;Zhu, Hong-Hu;Qin, Ya-Zhen
2018 High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy Qin, Ya-Zhen;Zhao, Ting;Zhu, Hong-Hu;Wang, Jing;Jia, Jin-Song;Lai, Yue-Yun;Zhao, Xiao-Su;Shi, Hong-Xia;Liu, Yan-Rong;Jiang, Hao;Huang, Xiao-Jun;Jiang, Qian
2017 High Expression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow Is Associated with Relapse in Adult B-cell Acute Lymphoblastic Leukemia Wang, Shu-Juan;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Huang, Xiao-Jun;Liu, Kai-Yan;Ruan, Guo-Rui
2017 High Expression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow Is Associated with Relapse in Adult B-cell Acute Lymphoblastic Leukemia Wang, Shu-Juan;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Huang, Xiao-Jun;Liu, Kai-Yan;Ruan, Guo-Rui
2017 High Expression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow Is Associated with Relapse in Adult B-cell Acute Lymphoblastic Leukemia Wang, Shu-Juan;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Huang, Xiao-Jun;Liu, Kai-Yan;Ruan, Guo-Rui
2011 Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase Jiang, Qian;Xu, Lan-Ping;Liu, Dai-Hong;Liu, Kai-Yan;Chen, Shan-Shan;Jiang, Bin;Jiang, Hao;Chen, Huan;Chen, Yu-Hong;Han, Wei;Zhang, Xiao-Hui;Wang, Yu;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Huang, Xiao-Jun
2016 Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation Qin, Ya-Zhen;Wang, Yu;Zhu, Hong-Hu;Gale, Robert Peter;Zhang, Mei-Jie;Jiang, Qian;Jiang, Hao;Xu, Lan-Ping;Chen, Huan;Zhang, Xiao-Hui;Liu, Yan-Rong;Lai, Yue-Yun;Jiang, Bin;Liu, Kai-Yan;Huang, Xiao-Jun
2013 MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial Zhu, Hong-Hu;Zhang, Xiao-Hui;Qin, Ya-Zhen;Liu, Dai-Hong;Jiang, Hao;Chen, Huan;Jiang, Qian;Xu, Lan-Ping;Lu, Jin;Han, Wei;Bao, Li;Wang, Yu;Chen, Yu-Hong;Wang, Jing-Zhi;Wang, Feng-Rong;Lai, Yue-Yun;Chai, Jun-Yue;Wang, Li-Ru;Liu, Yan-Rong;Liu, Kai-Yan;Jiang, Bin;Huang, Xiao-Jun
2013 NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes Liu, Yan-Rong;Zhu, Hong-Hu;Ruan, Guo-Rui;Qin, Ya-Zhen;Shi, Hong-Xia;Lai, Yue-Yun;Chang, Yan;Wang, Ya-Zhe;Lu, Dan;Hao, Le;Li, Jin-Lan;Li, Ling-Di;Jiang, Bin;Huang, Xiao-Jun
Apr-2020 Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma Wang, Zi-Long;Liu, Yang;Zhou, Ya-Lan;Li, Jin-Lan;Sun, Qiu-Yu;Wu, Li-Xin;Wen, Lei;Lai, Yue-Yun;Liu, Yan-Rong;Chang, Ying-Jun;Shi, Hong-Xia;Liu, Kai-Yan;Huang, Xiao-Jun;Lu, Jin;Ruan, Guo-Rui
Feb-2020 Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia Wang, Xiao-Rui;Chang, Yan;Yuan, Xiao-Ying;Wang, Ya-Zhe;Qin, Ya-Zhen;Ruan, Guo-Rui;Lai, Yue-Yun;Liu, Yan-Rong